“biotech-ipos” Archives

in
Entry Author Date Location
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More 10/09/20 National
Orphazyme Stock Sale Reaps $83M as Neimann-Pick Drug Review Begins 09/29/20 Europe
Praxis Precision Medicines Leads Way as Three More Biotechs Prep IPOs 09/28/20 Boston
Athira CEO Kawas: Alzheimer’s Drug Aims for “Recovery of Brain Function” 09/23/20 Seattle
Dyne’s Upsized IPO Brings In $233M for Muscle Disorders Drug R&D 09/17/20 Boston
Bio Roundup: COVID-19 Pact, Gavreto Approval, Generative Biology & More 09/11/20 National
Now Closer to Clinical Trials, Codiak BioSciences Refiles IPO Plans 09/10/20 Boston
Grail Files to Go Public; 5 More Life Science Firms Join the IPO Queue 09/09/20 National
Biotech Roundup: FDA Culpa, Tricida Trips, Freenome’s Funding & More 08/28/20 National
Athira Aims for the Nasdaq to Advance Alzheimer’s Drug to Phase 2 Tests 08/27/20 Seattle
CureVac’s IPO Hauls In $213M as Key mRNA COVID-19 Vaccine Test Nears 08/14/20 Europe
Bio Roundup: Seres Soars, MesoBlast Vote, Duchenne Decision & More 08/14/20 National
Bio Roundup: Cerevel’s Shell, Thrive’s Rise, Drug Price Drama & More 07/31/20 National
Freeline Therapeutics and Checkmate Pharma Make Opening IPO Moves 07/21/20 Europe
Two Days, Six IPOs, and $1B Raised for Biotech Research & More 07/17/20 National
Bio Roundup: Moderna Publishes, Life Science Cash, AdComm Votes & More 07/17/20 National
Shattuck Labs Nabs $118M for Cancer Drugs Like Keytruda, But Better 06/19/20 Raleigh Durham
Bio Roundup: A Royal IPO, Akili Arrives, Orca Bio Surfaces & More 06/19/20 National
Akouos Aims for an IPO to Advance Hearing Loss Gene Therapy to Clinic 06/08/20 Boston
Legend Biotech’s Upsized IPO Lands $424M for Multiple Myeloma Drug 06/05/20 New York
Bio Roundup: Race and Pharma, ASCO Recap, Warp Speed Ahead & More 06/05/20 National
Pliant Therapeutics Prices IPO, Lands $144M to Test Fibrosis Drugs 06/03/20 San Francisco
Generation Bio Leads a Trio of Biotech Companies Aiming for the Nasdaq 05/22/20 National
Pliant Pushes Forward With IPO Plans to Back Fibrosis Drug Studies 05/12/20 San Francisco
Keros Therapeutics Raises $96M in Upsized IPO to Fuel Clinical Tests 04/08/20 Boston
Bio Roundup: Biotech Billions, COVID-19 R&D, Zolgensma’s Path & More 04/03/20 National
Zentalis Leads a Trio of Biotechs Charting a Course for Wall Street 03/09/20 New York
Vir Bio’s IPO Brings In $143M for Tests of Hepatitis B Drug and More 10/11/19 San Francisco
Three Biotechs Raise $320M in IPOs, Two Others Pass on Wall Street 10/03/19 National
SpringWorks and Satsuma Boost This Week’s Biotech IPO Haul to $595M 09/12/19 San Francisco
Page 1 of 2 next page »